Modulating Target Protein Function through the Binding of Small Molecules

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Structure and Dynamics".

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 3652

Special Issue Editor


E-Mail Website
Guest Editor
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
Interests: computer aided drug design and discovery

Special Issue Information

Dear Colleagues,

This Special Issue aims to highlight the concept that small molecule binding can modulate target protein function in a variety of ways. Such ‘binders’ can affect protein activity through competitive, noncompetitive or uncompetitive binding. Particularly, ligand binding can influence not only protein structure but also protein dynamics. The latter expands the scope of a binder-based approach to translate small molecules to medicines, through the stabilization of pharmacologically desired conformational states of target proteins or by shifting the populations of different conformational states. We encourage contributions on the computational study of ligand binding altering the structure and dynamics of proteins, leading to: (1) inhibiting a function, (2) enhancing a function and (3) conferring a novel function of the proteins. Experimental studies addressing the mechanism for modulating protein function by small molecule binding are also of particular interest.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following: small molecule binding changes target protein structure, stability, and conformational dynamics, shifts protein conformational distributions, or alters interaction with its effector(s) or tendency to be chemically modified by cellular enzymes.

I look forward to receiving your contributions.

Dr. Xiaolin Cheng
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ligand binding
  • allosteric modulation
  • binding affinity
  • protein dynamics
  • conformational population shift
  • protein stability
  • protein–protein interactions

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

29 pages, 2603 KiB  
Review
Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies
by Said Moshawih, Ai Fern Lim, Chrismawan Ardianto, Khang Wen Goh, Nurolaini Kifli, Hui Poh Goh, Qais Jarrar and Long Chiau Ming
Biomolecules 2022, 12(7), 878; https://doi.org/10.3390/biom12070878 - 23 Jun 2022
Cited by 6 | Viewed by 3284
Abstract
Colorectal cancer is one of the most prevalent cancer types. Although there have been breakthroughs in its treatments, a better understanding of the molecular mechanisms and genetic involvement in colorectal cancer will have a substantial role in producing novel and targeted treatments with [...] Read more.
Colorectal cancer is one of the most prevalent cancer types. Although there have been breakthroughs in its treatments, a better understanding of the molecular mechanisms and genetic involvement in colorectal cancer will have a substantial role in producing novel and targeted treatments with better safety profiles. In this review, the main molecular pathways and driver genes that are responsible for initiating and propagating the cascade of signaling molecules reaching carcinoma and the aggressive metastatic stages of colorectal cancer were presented. Protein kinases involved in colorectal cancer, as much as other cancers, have seen much focus and committed efforts due to their crucial role in subsidizing, inhibiting, or changing the disease course. Moreover, notable improvements in colorectal cancer treatments with in silico studies and the enhanced selectivity on specific macromolecular targets were discussed. Besides, the selective multi-target agents have been made easier by employing in silico methods in molecular de novo synthesis or target identification and drug repurposing. Full article
Show Figures

Figure 1

Back to TopTop